 applic modifi bioassay serum teicoplanin vancomycin febril neutropen patient teicoplanin glycopeptid antibiot mode action spectrum activ similar vancomycin efficaci toler empir therapi pharmacokinet properti neutropen patient double-blind random trial comparison vancomycin agar diffus bioassay suitabl monitor level teicoplanin vancomycin serum combin therapi beta-lactam aminoglycosid serum sampl teicoplanin vancomycin reproduc result mean coeffici variat regardless presenc tobramycin amikacin piperacillin ceftazidim amphotericin combin patient teicoplanin schedul mg/kg steadi state day peak trough concentr teicoplanin serum steadi state mg/liter contrast patient vancomycin schedul mg/kg steadi state peak trough concentr serum mg/liter elimin half-liv teicoplanin separ approach accumul model gilbaldi perrier pharmacokinet degre renal function rowland clin pharmacokinet valu vancomycin